Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents.
- Published In:
- Neurochemical research, 30(12), 1493-500 (2005)
- Authors:
- Eremin, Kirill O, Kudrin, Vladimir S, Saransaari, Pirjo, Oja, Simo S, Grivennikov, Igor A, Myasoedov, Nikolay F, Rayevsky, Kirill S
- Database ID:
- RPEP-01031
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01031APA
Eremin, Kirill O; Kudrin, Vladimir S; Saransaari, Pirjo; Oja, Simo S; Grivennikov, Igor A; Myasoedov, Nikolay F; Rayevsky, Kirill S. (2005). Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents.. Neurochemical research, 30(12), 1493-500.
MLA
Eremin, Kirill O, et al. "Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents.." Neurochemical research, 2005.
RethinkPeptides
RethinkPeptides Research Database. "Semax, an ACTH(4-10) analogue with nootropic properties, act..." RPEP-01031. Retrieved from https://rethinkpeptides.com/research/eremin-2005-semax-an-acth410-analogue
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.